KHCM
TSVT

Kettle Hill Capital Management’s 2seventy bio TSVT Stock Holding History

Kettle Hill Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,900
Closed -$215K – 75
2022
Q4 		$215K Buy
22,900
+700
+3% +$9.87K 0.04% 45
2022
Q3 		$323K Buy
+22,200
New +$330K 0.08% 58

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kettle Hill Capital Management's TSVT Position: Q1 2023 in Review

Kettle Hill Capital Management sold out of 2seventy bio (TSVT) in Q1 2023, closing a stake of 22,900 shares — an estimated $215K sold.

Kettle Hill Capital Management first reported a position in TSVT in Q3 2022 and held it in 2 quarters. The position peaked at $323K in Q3 2022. 146 funds tracked by Wall St. Rank hold TSVT as of Q1 2023.

  • Kettle Hill Capital Management reported no remaining 2seventy bio position as of Q1 2023 after selling out during the quarter.
  • Kettle Hill Capital Management sold 22,900 2seventy bio shares in Q1 2023, an estimated $215K.
  • Kettle Hill Capital Management first reported a position in 2seventy bio in Q3 2022 and held it in 2 quarters.
  • Kettle Hill Capital Management's 2seventy bio position peaked at $323K in Q3 2022.
  • 146 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2023.

Based on Kettle Hill Capital Management's 13F filing for Q1 2023, filed 15 May 2023.